Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer - No Study Results Posted

Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer (TEAM)

This study is ongoing, but not recruiting participants.

Study NCT00279448 Information provided by Pfizer

First Received: January 17, 2006 Last Updated: November 20, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2011
Primary Completion Date:	November 2008 (Final data collection date for primary outcome measure)